Ribo Life Science Co., a leading company in small interfering RNA (siRNA) therapeutics, has successfully listed on the M...
US-based startup Xellar Biosystems, a globally leading innovator in next-generation artificial intelligence (AI)- a...
Pandorum Technologies, a clinical-stage regenerative medicine company building a next-generation platform for programmab...
Hong Kong headquartered Insilico Medicine, a leading artificial intelligence (AI)-driven drug discovery company, has ann...
Insilico Medicine, a clinical-stage drug discovery and development company driven by generative artificial intelligence ...
Asia-Pacific’s life sciences landscape has always been shaped by contrasts. It is a region where scale and sophist...
The Japanese government has stepped up efforts to strengthen its startup ecosystem, rolling out a series of initiatives ...
The COVID-19 pandemic acted as both a challenge and a catalyst, serving as a testbed that fundamentally reshaped the bio...
mRNA first entered the global spotlight during COVID-19, turning companies such as Moderna and BioNTech into household n...
The International Vaccine Institute (IVI) and the Korea Disease Control and Prevention Agency (KDCA), together with four...
China-based Jacobio Pharma has entered an agreement with AstraZeneca for its proprietary Pan-KRAS inhibitor JAB-23E73.&n...
Researchers in Australia have developed a new antimalarial drug candidate designed to address the growing challenge of d...
Japan-based Meiji Seika Pharma has entered into a partnership agreement with MBC BioLabs which is a private organisation...
Japan-based PRISM BioLab and US-based startup Talus Bioscience, Inc. have entered into a collaboration to discover novel...
China and US based Harbour BioMed has announced a multi-year, global strategic collaboration and license agreement ...
Galux, a South Korean biotech startup pioneering AI-driven protein therapeutics discovery, has signed a research agreeme...
MEDI&GENE, a South Korea-based biopharmaceutical company developing therapeutics for metabolic diseases, has entered...
Glenmark Specialty S.A. (GSSA), a wholly owned subsidiary of India-based Glenmark Pharmaceuticals, has entered into an e...
ADEL, Inc., a South Korea-based biopharmaceutical company dedicated to developing therapies for neurodegenerative diseas...
Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery company headquartered ...
Japan-based Chugai Pharmaceutical has announced the establishment of a new partnering office in South San Francisco, US....
D3 Bio, a global clinical-stage biotechnology company focused on the discovery and development of innovative oncology th...
Vietnam’s burgeoning tech ecosystem is poised to ignite a vibrant new era of cross-continental collaboration and i...
Singapore-based NUS Medicine’s Clinical Imaging Research Centre (CIRC), a leading academic centre for advanced mol...
The Research, Innovation and Enterprise 2030 (RIE2030) plan was endorsed at the 15th Research, Innovation and Enterprise...
